Table 3.

Comparisons of the changes in sFas levels in subjects with LAURC

Group	n	sFas level* (ng/L)	P
Pre-treatment
Control	31	5.53±1.13	<0.01
LAURC	47	8.79±1.39
Response (CR+PR)	39	8.50±1.25	<0.01
Non-response (SD+PD)	8	10.17±1.26
Post-treatment
Control	31	5.53±1.13	<0.01
LAURC	47	7.74±1.32
Response (CR+PR)	39	7.50±1.24	<0.01
Non-response (SD+PD)	8	8.90±1.13

^*Values are expressed as mean±SD